| 1 |
|
Synthesis and Biological Evaluation of Hyperforin Analogues. Part I. Modification of the Enolized Cyclohexanedione Moiety:
|
Verotta, L,Appendino, G,Belloro, E,Bianchi, F,Sterner, O,Lovati, M,Bombardelli, E
|
American Chemical Society
|
2002
|
|
|
|
| 2 |
|
Synthesis and Biological Evaluation of Oleanolic Acid Derivatives As Inhibitors of Protein Tyrosine Phosphatase 1B:
|
Qian, Shan,Li, Haijiao,Chen, Yin,Zhang, Weiyu,Yang, Shengyong,Wu, Yong
|
American Chemical Society
|
2010
|
|
|
|
| 3 |
|
Synthesis and Biological Evaluations of Enoxacin Carboxamide Derivaives:
|
Arayne,M.Saeed Sultana,Najma Haroon,Urooj Mesaik,M.Ahmed Asif,Muhammad
|
The Pharmaceutical Society of Korea
|
2009
|
|
|
|
| 4 |
|
Synthesis and biological evaluation of 3-(1H-indol-3-yl)pyrazole-5-carboxylic acid derivatives:
|
Zhang,Datong Wang,Guangtian Tan,Chubing Xu,Weiren Pei,Yuan Huo,Lingyan
|
The Pharmaceutical Society of Korea
|
2011
|
|
|
|
| 5 |
|
Synthesis and Biological Evaluation of 2,5-Diaminobenzamide Derivatives as Anti-proliferating Agents:
|
이진호 박종욱 온지은 박종원 이상효
|
The Pharmaceutical Society of Korea
|
2009
|
|
|
|
| 6 |
|
Synthesis and Biological Evaluation of Novel Imidazolone Derivatives as Potential COX-2 Inhibitors :
|
Hassanein,HassaneinH. Maha,M.Khalifa ElSamaloty,OlaN. ElRahim,MohamedAbd Taha,RagiaA Magda,M.F.Ismail
|
The Pharmaceutical Society of Korea
|
2008
|
|
|
|
| 7 |
|
Synthesis and Biological Evaluation of 1-Cyclohexyl Substituted 3-Aminopyrrolidine Derivatives as CC Chemokine Receptor 2 (CCR2) Antagonists:
|
임지웅 나용호 옥민호 김종훈 오유나 이승우 조희영 박우규 최길돈 김경락 강종민
|
The korean chemical society
|
2010
|
|
|
|
| 8 |
|
Synthesis and Biological Evaluation of Isophthalamide Derivatives as T-type Calcium Channel Blockers :
|
오유나 김윤지 서선희 이재균 림혜완 배애님 정규승 주현아 조용서
|
The korean chemical society
|
2008
|
|
|
|
| 9 |
|
Synthesis and biological evaluation of bergenin analogues as mushroom tyrosinase inhibitors :
|
Kashima Yusei, Miyazawa Mitsuo
|
The Pharmaceutical Society of Korea
|
2012
|
|
|
|
| 10 |
|
Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists:
|
Yu-Juan.Zhang; Liu-Lan.Shen; Hyae-Gyeong.Cheon; Yong-Nan.Xu; Jin-Hyun.Jeong
|
The Pharmaceutical Society of Korea
|
2014
|
|
|
|
